ZA918117B - Medicaments - Google Patents

Medicaments

Info

Publication number
ZA918117B
ZA918117B ZA918117A ZA918117A ZA918117B ZA 918117 B ZA918117 B ZA 918117B ZA 918117 A ZA918117 A ZA 918117A ZA 918117 A ZA918117 A ZA 918117A ZA 918117 B ZA918117 B ZA 918117B
Authority
ZA
South Africa
Prior art keywords
pct
date apr
sec
pub
headache
Prior art date
Application number
ZA918117A
Other languages
English (en)
Inventor
Alison Jane Pilgrim
Jane Pilgrim Alison
Original Assignee
Glaxo Group Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd filed Critical Glaxo Group Ltd
Publication of ZA918117B publication Critical patent/ZA918117B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Neurosurgery (AREA)
  • Indole Compounds (AREA)
ZA918117A 1990-10-12 1991-10-11 Medicaments ZA918117B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909022250A GB9022250D0 (en) 1990-10-12 1990-10-12 Medicaments

Publications (1)

Publication Number Publication Date
ZA918117B true ZA918117B (en) 1992-08-26

Family

ID=10683660

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA918117A ZA918117B (en) 1990-10-12 1991-10-11 Medicaments

Country Status (16)

Country Link
US (1) US5376672A (xx)
EP (1) EP0552205B1 (xx)
JP (1) JP3159263B2 (xx)
KR (1) KR0178762B1 (xx)
AT (1) ATE168006T1 (xx)
AU (1) AU660153B2 (xx)
CA (1) CA2093527A1 (xx)
DE (1) DE69129750T2 (xx)
DK (1) DK0552205T3 (xx)
ES (1) ES2118090T3 (xx)
GB (1) GB9022250D0 (xx)
IE (1) IE913580A1 (xx)
IL (1) IL99715A (xx)
TW (1) TW212756B (xx)
WO (1) WO1992006688A1 (xx)
ZA (1) ZA918117B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69435270D1 (de) * 1993-12-28 2010-04-01 Allergan Inc Verwendung der neurotoxischen Komponente von Botulinum Toxin zur Behandlung spastischer Muskeln
RU2180852C2 (ru) * 1994-12-12 2002-03-27 Омерос Медикл Системс, Инк. Ингибирующий раствор и способ подавления боли, воспаления или спазма
US20040068000A1 (en) * 2002-10-02 2004-04-08 Mintong Guo Compression coated tablets
US20080213363A1 (en) * 2003-01-23 2008-09-04 Singh Nikhilesh N Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
CA2569964A1 (en) * 2004-06-10 2005-12-29 Duramed Pharmaceuticals, Inc. Formulations of sumatriptan for absorption across biological membranes, and methods of making and using the same
EP2124556B1 (en) 2006-10-09 2014-09-03 Charleston Laboratories, Inc. Pharmaceutical compositions
EP2240022B1 (en) 2008-01-09 2016-12-28 Charleston Laboratories, Inc. Bilayered tablets comprising oxycodone and promethazine
US8304179B2 (en) * 2009-05-11 2012-11-06 Taiwan Semiconductor Manufacturing Company, Ltd. Method for manufacturing a semiconductor device using a modified photosensitive layer
US20100287502A1 (en) * 2009-05-11 2010-11-11 Olympus Imaging Corp. Image search device and image search method
EP3311667A1 (en) 2009-07-08 2018-04-25 Charleston Laboratories, Inc. Pharmaceutical compositions
CA3055170A1 (en) 2016-03-04 2017-09-08 Charleston Laboratories, Inc. Pharmaceutical compositions

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZW19381A1 (en) * 1980-08-12 1983-03-09 Glaxo Group Ltd Heterocyclic compounds
IT1170387B (it) * 1982-06-07 1987-06-03 Glaxo Group Ltd Composti eterociclici, procedimento per prepararli e composizioni farmaceutiche che li contengono
GB8332437D0 (en) * 1983-12-06 1984-01-11 Glaxo Group Ltd Chemical compounds
GB8419575D0 (en) * 1984-08-01 1984-09-05 Glaxo Group Ltd Chemical compounds
GB2162522B (en) * 1984-08-01 1988-02-24 Glaxo Group Ltd An indole derivative

Also Published As

Publication number Publication date
IL99715A (en) 1996-01-19
CA2093527A1 (en) 1992-04-13
EP0552205A1 (en) 1993-07-28
IE913580A1 (en) 1992-04-22
DE69129750T2 (de) 1998-11-12
US5376672A (en) 1994-12-27
KR0178762B1 (ko) 1999-03-20
ES2118090T3 (es) 1998-09-16
GB9022250D0 (en) 1990-11-28
IL99715A0 (en) 1992-08-18
JP3159263B2 (ja) 2001-04-23
DK0552205T3 (da) 1999-04-19
AU660153B2 (en) 1995-06-15
EP0552205B1 (en) 1998-07-08
AU8642291A (en) 1992-05-20
JPH06501935A (ja) 1994-03-03
ATE168006T1 (de) 1998-07-15
TW212756B (xx) 1993-09-11
WO1992006688A1 (en) 1992-04-30
DE69129750D1 (de) 1998-08-13

Similar Documents

Publication Publication Date Title
MY112915A (en) Multiple unit tableted dosage form 1
EG22373A (en) New pharmaceutical formulation
PH30438A (en) Heterocyclic amines useful in the therapy of asthma and inflammation of the respiratory tract
CO4340681A1 (es) Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero
NO952229D0 (no) Anvendelse av karbamazepin og okskarbazepin ved behandling av neurologiske lesjoner relatert til traumatiske skader
IT1274879B (it) Apparecchio e metodo per preparare forme farmaceutiche solide a rilascio controllato del principio attivo.
TR199902253T2 (xx) �n g�z odac���nda farmas�tik maddelerin kontroll� sal�n�m�.
DE69326776D1 (de) Verwendung von n-arylmethylen ethylendiamintriacetate, n-arylmethylen iminodiacetat oder n,n'-diarylmethylen ethylendiamindiacetat gegen oxidativen stress
GB9022250D0 (en) Medicaments
HU9502065D0 (en) Application of carbamazepine and oxcarbazepine in the treatment of parkinson's disease and parkinsonian syndromes
PL312219A1 (en) Application of nona- and decapeptides in obtaining a therapeutic agent for fighting against aids
AU3078892A (en) Human interleukin-8 analogs
ZA981779B (en) The use of levobupivacaine in facial surgery
TW261532B (xx)
AU5818394A (en) Use of prodelphinidines for treating arthrosis
SE9101840L (sv) Ny medicinsk anvaendning
HU913814D0 (en) Medicament for treating hyperlipidaemia and/or atherosclerosis
HU9300243D0 (en) 1-(b-d-arabino-furanosyl)-5-propinyl-uracyl compounds
HK1011280A1 (en) Use of 4'iodo-4'- deoxydoxorubicin for the treatment of amyloidosis
HUT77175A (hu) Szelegilin alkalmazása epilepsziás betegségek kezelésére használható gyógyszerkészítmények előállítására és szelegilint tartalmazó epilepsziaellenes gyógyszerkészítmények
HK1005651A1 (en) Use of forskolin or extracts containing it in the manufacture of a medicament for the treatment of alcohol addiction
ZA983211B (en) Use of mizolastine for preparing medication for the treatment of inflammation
GR3036205T3 (en) Use of phosphorus derivatives of alkaloids for treating endocrinopathies